Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.
2.

Levodopa in Mucuna pruriens and its degradation.

Pulikkalpura H, Kurup R, Mathew PJ, Baby S.

Sci Rep. 2015 Jun 9;5:11078. doi: 10.1038/srep11078.

3.

Effects of Antidepressants on DSP4/CPT-Induced DNA Damage Response in Neuroblastoma SH-SY5Y Cells.

Wang Y, Hilton BA, Cui K, Zhu MY.

Neurotox Res. 2015 Aug;28(2):154-70. doi: 10.1007/s12640-015-9534-z. Epub 2015 Jun 3.

4.

Evaluation of the Cytotoxicity of Levodopa and its Complex with Hydroxypropyl-ß-Cyclodextrin (HP-ß-CD) to an Astrocyte Cell Line.

Sofian ZM, Shafee SS, Abdullah JM, Osman H, Razak SA.

Malays J Med Sci. 2014 Dec;21(Spec Issue):6-11.

5.

The high-affinity D2/D3 agonist D512 protects PC12 cells from 6-OHDA-induced apoptotic cell death and rescues dopaminergic neurons in the MPTP mouse model of Parkinson's disease.

Shah M, Rajagopalan S, Xu L, Voshavar C, Shurubor Y, Beal F, Andersen JK, Dutta AK.

J Neurochem. 2014 Oct;131(1):74-85. doi: 10.1111/jnc.12767. Epub 2014 Jun 21.

6.

Toxicity and metabolism of layered double hydroxide intercalated with levodopa in a Parkinson's disease model.

Kura AU, Ain NM, Hussein MZ, Fakurazi S, Hussein-Al-Ali SH.

Int J Mol Sci. 2014 Apr 9;15(4):5916-27. doi: 10.3390/ijms15045916.

7.

The role of L-DOPA in plants.

Soares AR, Marchiosi R, Siqueira-Soares Rde C, Barbosa de Lima R, Dantas dos Santos W, Ferrarese-Filho O.

Plant Signal Behav. 2014;9(3):e28275. Epub 2014 Mar 4. Review.

8.

Epigallocatechin gallate attenuates L-DOPA-induced apoptosis in rat PC12 cells.

Lee MY, Choi EJ, Lee MK, Lee JJ.

Nutr Res Pract. 2013 Aug;7(4):249-55. doi: 10.4162/nrp.2013.7.4.249. Epub 2013 Aug 7.

9.

Multisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brain.

Navailles S, Lagière M, Contini A, De Deurwaerdère P.

ACS Chem Neurosci. 2013 May 15;4(5):680-92. doi: 10.1021/cn400046e. Epub 2013 Apr 15. Review.

10.

L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells.

Stansley BJ, Yamamoto BK.

Neuropharmacology. 2013 Apr;67:243-51. doi: 10.1016/j.neuropharm.2012.11.010. Epub 2012 Nov 27.

11.

Resveratrol attenuates L-DOPA-induced hydrogen peroxide toxicity in neuronal cells.

Peritore CS, Ho A, Yamamoto BK, Schaus SE.

Neuroreport. 2012 Dec 5;23(17):989-94. doi: 10.1097/WNR.0b013e32835a4ea4.

12.

Oxidative stress and microglial cells in Parkinson's disease.

Peterson LJ, Flood PM.

Mediators Inflamm. 2012;2012:401264. doi: 10.1155/2012/401264. Epub 2012 Mar 22.

13.

Effect of chronic L-dopa or melatonin treatments after dopamine deafferentation in rats: dyskinesia, motor performance, and cytological analysis.

Gutierrez-Valdez AL, Anaya-Martínez V, Ordoñez-Librado JL, García-Ruiz R, Torres-Esquivel C, Moreno-Rivera M, Sánchez-Betancourt J, Montiel-Flores E, Avila-Costa MR.

ISRN Neurol. 2012;2012:360379. doi: 10.5402/2012/360379. Epub 2012 Feb 1.

14.

MPP(+)-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress.

Hsieh YC, Mounsey RB, Teismann P.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Aug;384(2):157-67. doi: 10.1007/s00210-011-0660-8. Epub 2011 Jun 12.

15.
16.
17.
18.

Pharmacological treatment of Parkinson's disease.

Münchau A, Bhatia KP.

Postgrad Med J. 2000 Oct;76(900):602-10. Review. No abstract available.

19.

Manganese increases L-DOPA auto-oxidation in the striatum of the freely moving rat: potential implications to L-DOPA long-term therapy of Parkinson's disease.

Serra PA, Esposito G, Enrico P, Mura MA, Migheli R, Delogu MR, Miele M, Desole MS, Grella G, Miele E.

Br J Pharmacol. 2000 Jun;130(4):937-45.

Supplemental Content

Support Center